A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Filters
Integrative deep-sequencing analysis of cancer samples: discoveries and clinical challenges
2013
The Pharmacogenomics Journal
Preserved Fulltext
platforms to provide valid deep-sequencing data with WGS, whole-exome sequencing and RNA-seq in clinical samples in a short time has resulted in the new era of clinical cancer genome. 1 Genomic heterogeneity ...
Here, I discuss the results of the first published studies with deep-sequencing and transcriptomic analysis data of clinical samples from roughly 2400 breast cancer and 1125 medulloblastoma patients. ...
CONFLICT OF INTEREST The author declares no conflict of interest. ...
doi:10.1038/tpj.2012.51
pmid:23296155
fatcat:ixorenutmvcd3pvfhqag6r5keq
Stratification of Breast Cancer by Integrating Gene Expression Data and Clinical Variables
2019
Molecules
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Clinical data is another promising source. In this study, clinical variables are utilized and integrated to gene expressions for the stratification of breast cancer. ...
Breast cancer is a heterogeneous disease. Although gene expression profiling has led to the definition of several subtypes of breast cancer, the precise discovery of the subtypes remains a challenge. ...
Materials and Methods
Data Preprocessing The Cancer Genome Atlas (TCGA) RNA-Seq data and clinical information of breast carcinoma were downloaded from the University of California Santa Cruz (UCSC) cancer ...
doi:10.3390/molecules24030631
fatcat:knmneqsmjnbh7bg6jlctsqa37q
Analysis of H3K4me3-ChIP-Seq and RNA-Seq data to understand the putative role of miRNAs and their target genes in breast cancer cell lines
2021
Genomics & Informatics
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Acknowledgments The authors thank the BRAF facility of C-DAC for HPC infrastructure. The authors would also like to deeply thank Dr. Janaki C.H. for her scientific review and critical comments. ...
The workflow for ChIP-Seq and RNA-Seq data integration is depicted in Fig. 1B . ...
using ChIP-Seq-RNA-Seq integrated analysis No. ...
doi:10.5808/gi.21020
fatcat:5wj5vpm7kvd63heu5j72ngqopq
Single-cell RNA-seq dissects the intratumoral heterogeneity of triple negative breast cancer based on gene regulatory networks
2021
Molecular Therapy: Nucleic Acids
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with high intratumoral heterogeneity. ...
In conclusion, the construction of GRNs based on scRNA-seq data could help us to dissect the intratumoral heterogeneity and identify the critical genes of TNBC. ...
Hence, traditional analysis of breast cancer based on bulk RNA-seq would be quite insufficient. ...
doi:10.1016/j.omtn.2020.12.018
pmid:33575114
pmcid:PMC7851423
fatcat:bk5hv4er7remhjpkq2jr2s36ey
Hypoxanthine Phosphoribosyl Transferase 1 Is Upregulated, Predicts Clinical Outcome and Controls Gene Expression in Breast Cancer
2020
Cancers
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Further, in breast cancer, the subtype-specific analysis showed that its expression was highest in basal and triple-negative breast cancer, and HPRT1 knockdown in breast cancer cells suggested that HPRT1 ...
Hypoxanthine phosphoribosyl transferase 1 (HPRT1) is traditionally believed to be a housekeeping gene; however, recent reports suggest that it is upregulated in several cancers and is associated with clinical ...
Acknowledgments: The authors thank members of the Gadad lab. for their suggestions and comments. The authors thank proteomics core at UT Southwestern Medical Center for TMT analysis. ...
doi:10.3390/cancers12061522
pmid:32532008
fatcat:tlsw2c45ejd27m6i6dmzv22rsy
Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain
2020
BMC Medical Genomics
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
We identify distinctive epigenomic properties of breast cancer cells that metastasize to the lung and brain. ...
To identify these, we performed RNA-seq, Chromatin Immunoprecipitation and sequencing (ChIP-seq) and Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) of the MDA-MB-231 cell line and ...
Acknowledgements Sequencing was conducted at Yale Stem Cell Center Genomics Core facility which was supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation. ...
doi:10.1186/s12920-020-0695-0
pmid:32143622
pmcid:PMC7060551
fatcat:ugyh7weisnemnfftecfq5o36fu
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer
2018
Journal of Clinical Investigation
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
We identified tumor-specific drivers by integrating known protein-protein network information with RNA expression and somatic DNA alterations and found that genetic drivers were predominantly established ...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple sites of the disease. ...
Komen (to LAC and CMP); National Cancer Institute (NCI), NIH, Breast Specialized Programs of Research Excellence (SPOREs) (P50-CA58223, to LAC and CMP; RO1-CA195754-01 and RO1- ...
doi:10.1172/jci96153
pmid:29480819
pmcid:PMC5873890
fatcat:7zxgh5ltqbet5dhyotghibtz5e
Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients
2016
BMC Genomics
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Interestingly, we identified a stable subgroup of breast cancer patients that are highly enriched with ER-negative and triple-negative subtypes, and the somatic mutation genes they harbor were capable ...
We developed a novel approach for integrating patient somatic mutation, transcriptome and clinical data to mine underlying functional gene groups that can be used to stratify cancer patients into groups ...
Availability of data and materials All datasets used in this study were publicly available from the website described in the Methods section. ...
doi:10.1186/s12864-016-2902-0
pmid:27556157
pmcid:PMC5001235
fatcat:n3uaea2hdzbqnk6r75wpjfv6q4
The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis
2016
EBioMedicine
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Furthermore, integration of RNA-seq and ChIP-chip data reveals that RORγ regulates the expression of many genes involved in TGF-β/EMT-signaling, DNA-repair and MaSC pathways (including the non-coding RNA ...
We demonstrate that RORγ expression is: (i) decreased in basal-like subtype cancers, and (ii) inversely correlated with histological grade and drivers of carcinogenesis in breast cancer cohorts. ...
The authors declare there are no conflicts of interest and/or competing interests to disclose. ...
doi:10.1016/j.ebiom.2016.02.028
pmid:27211549
pmcid:PMC4856749
fatcat:5yopccbdxzf4nbuqazflo4p4li
Molecular natural history of breast cancer: Leveraging transcriptomics to predict breast cancer progression and aggressiveness
2020
Cancer Medicine
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
cells (specifically, single-cell topological data analysis and Wanderlust) to create a continuous metric describing breast cancer progression using bulk RNA-seq samples from individual patient tumors. ...
We also created a linear regression-based method to predict tumor aggressiveness in vivo from bulk RNA-seq data. ...
based on RNA-seq data from clinical patients. ...
doi:10.1002/cam4.2996
pmid:32207233
fatcat:nd4ipb5g2jfkzojecndfe45m7y
A comprehensive long-read isoform analysis platform and sequencing resource for breast cancer
2022
Science Advances
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Together, our results demonstrate the complexity, cancer subtype specificity, and clinical relevance of previously unidentified isoforms and splicing events in breast cancer that are only annotatable by ...
Of these, 21 are absent from GENCODE and 10 are enriched in specific breast cancer subtypes. ...
Our analyses identified tumor-specific isoforms, including isoforms associated with poor survival and specific breast cancer subtypes, and provide a library of novel breast tumor-specific isoforms as a ...
doi:10.1126/sciadv.abg6711
pmid:35044822
pmcid:PMC8769553
fatcat:f3pzpq2jyfexfkmr2q2wphr7um
Long intergenic non-coding RNA expression signature in human breast cancer
2016
Scientific Reports
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
To further use lincRNAs as robust biomarkers, we performed an integrative analysis on RNA-seq data from approximately 1,000 breast tumors from the TCGA and an independent RNA-seq dataset of 50 pairs of ...
We designed a two-stage study, including 1,000 breast tumor RNA-seq data from The Cancer Genome Atlas (TCGA) as the discovery stage, and RNA-seq data of matched tumor and adjacent normal tissue from 50 ...
We also thank the Indiana University Simon Cancer Center at Indiana University School of Medicine for the use of the Tissue Procurement & Distribution Core, which provided breast tumor specimens. ...
doi:10.1038/srep37821
pmid:27897201
pmcid:PMC5126689
fatcat:cjg5buggxzhyvout3ia4odotmq
SURVIV for survival analysis of mRNA isoform variation
2016
Nature Communications
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
The rapid accumulation of clinical RNA-seq data sets has provided the opportunity to associate mRNA isoform variations to clinical outcomes. ...
We applied SURVIV to TCGA RNA-seq data of invasive ductal carcinoma as well as five additional cancer types. ...
Acknowledgements This study is supported by National Institutes of Health grants (R01GM088342 and R01GM105431 to Y.X.), and National Science Foundation grant (DMS 1310391 to Y.N.W.). ...
doi:10.1038/ncomms11548
pmid:27279334
pmcid:PMC4906168
fatcat:2bxqeiylmnewfnsihgyo3mpzim
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer
2020
Genes
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
In this study, we conducted a comprehensive analysis of STs in the clinical database and identified the STs related with the survival of breast cancer patients. ...
RNA sequencing (RNA-Seq) data of 496 patients were obtained from The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA). ...
The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. ...
doi:10.3390/genes11121436
pmid:33260650
fatcat:ggsqeman2jc4nmspjvqdcaaf2m
Ror2 Signaling and Its Relevance in Breast Cancer Progression
2017
Frontiers in Oncology
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
The results were further used in the analysis of an independent dataset of breast cancer patients with metastasis-free survival annotation. ...
Furthermore, the genes of the Ror2/Wnt module were assessed as a gene signature in patient gene expression data and showed an association with clinical outcome. ...
Gene Set Enrichment and Network Integration Analyses Differential targets identified in the analysis of RNA-Seq data were further subjected to enrichment and network integration analyses. ...
doi:10.3389/fonc.2017.00135
pmid:28695110
pmcid:PMC5483589
fatcat:ssctjfqyjbeglayt3357sv5uzq
« Previous
Showing results 1 — 15 out of 6,376 results